Global Nuclear Medicine/ Radiopharmaceuticals Market Set for Rapid Growth, to reach Value USD 14.11 Billion by 2025

Nuclear Medicine/ Radiopharmaceuticals Market by Type (Therapeutic and Diagnostic), Procedures (Cardiovascular, Oncology, Central Nervous System, Skeletal, Endocrine, Gastrointestinal, Pulmonary, and Others), Application (Cardiology, Oncology, Thyroid, Neurology, and Others), and End User (Research Institutes, Hospitals, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025” According to the report, global demand for nuclear medicine/ radiopharmaceuticals market was valued at approximately USD 5.82 Billion in 2018, and is expected to generate revenue of around USD 14.11 Billion by end of 2025, growing at a CAGR of around 13.6% between 2018 and 2025.

Browse the full “Nuclear Medicine/Radiopharmaceuticals Market by Type (Therapeutic and Diagnostic), Procedures (Cardiovascular, Oncology, Central Nervous System, Skeletal, Endocrine, Gastrointestinal, Pulmonary, and Others), Application (Cardiology, Oncology, Thyroid, Neurology, and Others), and End User (Research Institutes, Hospitals, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025” Report at https://www.zionmarketresearch.com/report/nuclear-medicine-radiopharmaceuticals-market

Nuclear medicine is a domain that employs radioactive materials to diagnose and treat diseases. The radiopharmaceuticals used in radioactive compounds and nuclear medicine are administered to the patient, and analyzed via particular imaging devices for therapy and diagnosis. PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) are the couple of most widely used imaging modalities in nuclear medicine.

Factors such as growth in cases of cancer along with other target disorders, targeted cancer therapy with the assistance of alpha radio immunotherapy, efforts taken to bridge the demand-supply difference of Mo-99, suitability of treatment, execution of clear imaging process, and technological developments will act as major driving factors in the growth of global nuclear medicine/ radiopharmaceuticals market. Radiopharmaceutical applications in neurology and promising government policies in emerging regions will act as an opportunity for the market players in the nuclear medicine/ radiopharmaceuticals market. Nonetheless, small half-life of radiopharmaceuticals, scarcity in supply, problems in logistics, lack of skilled workforces, and deficiency of consciousness in low income regions will restrict the growth of global nuclear medicine/ radiopharmaceuticals market.

The global nuclear medicine/ radiopharmaceuticals market has been split into type, procedures, application, and end user. Based on type, nuclear medicine/ radiopharmaceuticals market has been segmented into therapeutic and diagnostic. The diagnostic segment accounted for the highest market share in 2018 due to growing patient population, rising awareness regarding use of nuclear medicine, and availability of new radioisotopes.

The therapeutic segment has been divided into alpha emitters, beta emitters, and brachytherapy isotopes. The diagnostic segment has been divided into PET radiopharmaceuticals and SPECT radiopharmaceuticals. The procedures segment has been segmented into cardiovascular, oncology, central nervous system, skeletal, endocrine, gastrointestinal, pulmonary, and others.

The application segment has been segmented into cardiology, oncology, thyroid, neurology, and others. The oncology segment accounted for the highest market share in 2018 due to increase in number of cancer cases and use of F-18 isotope. The end user segment has been segmented into research institutes, hospitals, diagnostic centers, and others.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America will be the leading region during the forecast period. Development of unique technologies for the production of isotopes, presence of leading market players, and rapid uptake of new technologies will boost the market growth in this region. Europe will be the second largest market. The major reasons are presence of skilled professionals, rise in awareness regarding use of nuclear medicine, high cancer prevalence, and favorable reimbursement scenario. Asia Pacific will propagate at speedy rate over the forecast period due to rapid technological updation in the healthcare sector and increasing cases of cancer and other chronic ailments. Latin America market will develop at a significant rate during the forecast period. The Africa and Middle Eastern countries are likely to experience perceptible growth in the estimated time-frame.

The report also includes detailed profiles of key players such as GE Healthcare, Curium, Cardinal Health, Bayer, Advanced Accelerator Applications, Lantheus Medical Imaging, and Jubilant Life Sciences among others.

This report segments the Global Nuclear Medicine/Radiopharmaceuticals Market as follows:

Global Nuclear Medicine/Radiopharmaceuticals Market: By Type

• Therapeutic

• Alpha Emitters
• Beta Emitters
• Brachytherapy Isotopes

• Diagnostic

• PET Radiopharmaceuticals
• SPECT Radiopharmaceuticals

Global Nuclear Medicine/Radiopharmaceuticals Market: By Procedures

• Cardiovascular
• Oncology
• Central Nervous System
• Skeletal
• Endocrine
• Gastrointestinal
• Pulmonary
• Others

Global Nuclear Medicine/Radiopharmaceuticals Market: By Application

• Cardiology
• Oncology
• Thyroid
• Neurology
• Others

Global Nuclear Medicine/Radiopharmaceuticals Market: By End User

• Research Institutes
• Hospitals
• Diagnostic Centers
• Others

Global Nuclear Medicine/Radiopharmaceuticals Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com